Annual Cash & Cash Equivalents
$124.29M$19.45M-13.53%
Summary
- Current Value
- As of today, RLAY annual cash & cash equivalents is $124.29M, down -13.53% on
- Historical Performance
- RLAY annual cash & cash equivalents is down -55.63% over the past 3 years, and up +196.25% over the past 5 years
- All-Time High Comparison
- RLAY annual cash & cash equivalents is currently -72.24% below its historical high of $447.65M set on
- 3-Year Low Comparison
- RLAY annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- RLAY annual cash & cash equivalents is higher than 69.83% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $124.29M | -13.5% | -55.6% | +196.3% | -70.5% | |
| Quarterly Cash & Cash Equivalents | $596.43M | -29.0% | -43.4% | -16.4% | – | |
| Price | $8.00 | +65.6% | -49.2% | -80.3% | – | |
| Annual Current Assets | $809.20M | +5.1% | -17.1% | +124.4% | +90.8% | |
| Annual Total Liabilities | $93.50M | +1.7% | -15.5% | +161.7% | +1160.5% | |
| Annual Working Capital | $758.48M | +2.5% | -20.3% | +117.6% | +81.8% | |
| Annual Net Income | -$337.71M | +1.3% | +7.2% | -348.4% | -592.2% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $151.79M | N/A | -18.1% |
| 5Y | $447.65M | N/A | -72.2% |
| All | $447.65M | -72.2% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $124.29M | at low | |
| 5Y | $124.29M | at low | |
| All | $41.95M | +196.3% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $124.29M | -13.5% | |
| $143.74M | -5.3% | |
| $151.79M | -45.8% | |
| $280.12M | -37.4% |
| Year | Value | Change |
|---|---|---|
| $447.65M | +967.0% | |
| $41.95M | -90.0% | |
| $421.51M | - |
FAQ
What is the current annual cash & cash equivalents of RLAY?
As of today, RLAY annual cash & cash equivalents is $124.29M
What is 1-year change in RLAY annual cash & cash equivalents?
RLAY annual cash & cash equivalents is down -13.53% year-over-year
What is 3-year change in RLAY annual cash & cash equivalents?
RLAY annual cash & cash equivalents is down -55.63% over the past 3 years
How far is RLAY annual cash & cash equivalents from its all-time high?
RLAY annual cash & cash equivalents is currently -72.24% below its historical high of $447.65M set on December 31, 2020
How does RLAY annual cash & cash equivalents rank versus sector peers?
RLAY annual cash & cash equivalents is higher than 69.83% of companies in Healthcare sector
When is RLAY next annual earnings release?
The next annual earnings release for RLAY is on
Quarterly Cash & Cash Equivalents
$596.43M$60.34M-9.19%
Summary
- Current Value
- As of today, RLAY quarterly cash & cash equivalents is $596.43M, down -9.19% on
- Historical Performance
- RLAY quarterly cash & cash equivalents is down -28.96% year-over-year, and down -43.40% over the past 3 years
- All-Time High Comparison
- RLAY quarterly cash & cash equivalents is currently -43.40% below its historical high of $1.05B set on
- 3-Year Low Comparison
- RLAY quarterly cash & cash equivalents is at its 3-year low
- Sector Comparison
- RLAY quarterly cash & cash equivalents is higher than 87.71% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $596.43M | -9.2% | -29.0% | -43.4% | -16.4% | |
| Annual Cash & Cash Equivalents | $124.29M | – | -13.5% | -55.6% | +196.3% | |
| Price | $8.00 | +30.9% | +65.6% | -49.2% | -80.3% | |
| Quarterly Current Assets | $624.01M | -8.3% | -27.9% | -42.6% | -13.6% | |
| Quarterly Total Liabilities | $62.29M | -1.4% | -31.7% | -63.1% | +63.3% | |
| Quarterly Working Capital | $591.41M | -8.7% | -27.7% | -41.8% | -16.3% | |
| Quarterly Net Income | -$74.15M | -5.4% | +15.8% | +11.9% | -105.5% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $781.32M | N/A | -23.7% |
| 3Y | $998.92M | N/A | -40.3% |
| 5Y | $1.05B | -43.4% | |
| All | $1.05B | -43.4% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $596.43M | at low | |
| 3Y | $596.43M | at low | |
| 5Y | $596.43M | at low | |
| All | $312.21M | +91.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of RLAY?
As of today, RLAY quarterly cash & cash equivalents is $596.43M
What is RLAY quarterly cash & cash equivalents most recent change?
RLAY quarterly cash & cash equivalents was down -9.19% on September 30, 2025
What is 1-year change in RLAY quarterly cash & cash equivalents?
RLAY quarterly cash & cash equivalents is down -28.96% year-over-year
How far is RLAY quarterly cash & cash equivalents from its all-time high?
RLAY quarterly cash & cash equivalents is currently -43.40% below its historical high of $1.05B set on September 30, 2022
How does RLAY quarterly cash & cash equivalents rank versus sector peers?
RLAY quarterly cash & cash equivalents is higher than 87.71% of companies in Healthcare sector
When is RLAY next earnings release?
The next earnings release for RLAY is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- RLAY Official Website www.relaytx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1812364/000119312525269601/0001193125-25-269601-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1812364/000095017025027756/0000950170-25-027756-index.htm
- RLAY Profile on Yahoo Finance finance.yahoo.com/quote/RLAY
- RLAY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rlay